Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
103
Frequently Asked Questions
What is Market Cap of Lexicon Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lexicon Pharmaceuticals Inc market cap is $490.59M.
What is the 52-week high for Lexicon Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lexicon Pharmaceuticals Inc 52 week high is $2.18 as of October 02, 2025.
What is the 52-week low for Lexicon Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lexicon Pharmaceuticals Inc 52 week low is $0.2836 as of October 02, 2025.
What is Lexicon Pharmaceuticals Inc stock price today?
Lexicon Pharmaceuticals Inc stock price today is $1.41.
What was Lexicon Pharmaceuticals Inc stock price yesterday?
Lexicon Pharmaceuticals Inc stock price yesterday was $1.35.
What is the PE ratio of Lexicon Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lexicon Pharmaceuticals Inc’s P/E ratio is -4.05.
What is the Price-to-Book ratio of Lexicon Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lexicon Pharmaceuticals Inc P/B ratio is 3.7901.
What is the 50-day moving average of Lexicon Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lexicon Pharmaceuticals Inc 50-day moving average is $1.15.
How many employess does Lexicon Pharmaceuticals Inc has?
LXRX Lexicon Pharmaceuticals Inc